Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Molecular Partners Ag ADR (MOLN)

Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 GlobeNewswire - Thu Nov 7, 3:00PM CST

MOLN : 5.29 (-2.49%)
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition GlobeNewswire - Tue Nov 5, 3:00PM CST

MOLN : 5.29 (-2.49%)
Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going GlobeNewswire - Thu Oct 31, 3:00PM CDT

MOLN : 5.29 (-2.49%)
Molecular Partners Announces Pricing of $20 Million Underwritten Offering GlobeNewswire - Fri Oct 25, 12:00AM CDT

MOLN : 5.29 (-2.49%)
Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 GlobeNewswire - Tue Oct 22, 12:00AM CDT

MOLN : 5.29 (-2.49%)
Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics GlobeNewswire - Tue Oct 22, 12:00AM CDT

MOLN : 5.29 (-2.49%)
Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting GlobeNewswire - Fri Oct 4, 12:00AM CDT

MOLN : 5.29 (-2.49%)
Author
Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy MarketBeat - Tue Mar 7, 2023

Ambrx Pharmaceuticals, Inc. could see positive earnings next year. And while share value could go down, analysts thin rate AMAM a Moderate Buy

AMAM : 28.00 (+0.07%)
MOLN : 5.29 (-2.49%)
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody Business Wire - Mon Oct 3, 2022

Incyte (NASDAQ:INCY) today announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development...

INCY : 71.72 (+1.89%)
MOLN : 5.29 (-2.49%)
PCVX : 88.54 (+0.17%)
AURA : 8.95 (-0.89%)
CNTA : 17.04 (-6.32%)
Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Molecular Partners AG (MOLN) Investors of Class Action and Last Few Hours to Actively Participate Business Wire - Mon Sep 12, 2022

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Molecular Partners AG (“Molecular Partners” or the “Company”) (NASDAQ:...

MOLN : 5.29 (-2.49%)

Barchart Exclusives

How to Invest for Kids: Understanding the Basics Barchart - Sat Nov 23, 1:30PM CST
A good way to show kids the value of compounding money is to ask if they’d rather have a $100 bill today or a penny that doubles every day for 30 days. They will be surprised to hear that in 30 days, that penny would be worth about $5.4 million dollars! Here's a guide to the types of accounts you can open for your children or grandchildren. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot